Please use this identifier to cite or link to this item:
|Title:||An overview of nanomedicines for neuron targeting|
Paraiso, West Kristian D.
Serra i Cucurull, Dolors
Herrero Rodríguez, Laura
García Gómez, Jordi
Ariza Piquer, Xavier
Administració de medicaments
Administration of drugs
|Abstract:||Medical treatments of neuron-related disorders are limited due to the difficulty of targeting brain cells. Major drawbacks are the presence of the blood-brain barrier and the lack of specificity of the drugs for the diseased cells. Nanomedicine-based approaches provide promising opportunities for overcoming these limitations. Although many previous reviews are focused on brain targeting with nanomedicines in general, none of those are concerned explicitly on the neurons, while targeting neuronal cells in central nervous diseases is now one of the biggest challenges in nanomedicine and neuroscience. We review the most relevant advances in nanomedicine design and strategies for neuronal drug delivery that might successfully bridge the gap between laboratory and bedside treatment in neurology.|
|Note:||Versió postprint del document publicat a: https://doi.org/10.2217/nnm-2020-0088|
|It is part of:||Nanomedicine, 2020, vol. 15, num. 16, p. 1617-1636|
|Appears in Collections:||Articles publicats en revistes (Química Inorgànica i Orgànica)|
Document embargat fins el 3-7-2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.